RSCI (Redwood Scientific Technologies) Forward Dividend Yield %: 0.00% (As of Jul. 11, 2026)


What is Redwood Scientific Technologies Forward Dividend Yield %?

Redwood Scientific Technologies RSCI Forward Dividend Yield % is 0.00% as of Jul. 11, 2026.

As of today (2026-07-11), the Forward Annual Dividend Yield of Redwood Scientific Technologies is 0.00%.

As of today (2026-07-11), the Trailing Annual Dividend Yield of Redwood Scientific Technologies is 0.00%.

RSCI's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2
* Ranked among companies with meaningful Forward Dividend Yield % only.

Redwood Scientific Technologies's Dividends per Share for the six months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Redwood Scientific Technologies  (OTCPK:RSCI) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Redwood Scientific Technologies Forward Dividend Yield % Related Terms

RSCI vs RAPH, FLGC, TXMD: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's Forward Dividend Yield % falls into.


Redwood Scientific Technologies Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Redwood Scientific Technologies (RSCI) has a Forward Dividend Yield % of 0.00% as of Jul. 11, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' Forward Dividend Yield % too high?
Redwood Scientific Technologies' current Forward Dividend Yield % is 0.00%.
How does Redwood Scientific Technologies' Forward Dividend Yield % compare to RAPH and FLGC?
Redwood Scientific Technologies' Forward Dividend Yield % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Forward Dividend Yield % is 2.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.00, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Redwood Scientific Technologies and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redwood Scientific Technologies's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current Forward Dividend Yield % is 0.00% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.